Pelham, NY, United States of America

Barry Jay Kappel

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Barry Jay Kappel: Innovator in Peptide Technology

Introduction

Barry Jay Kappel is a notable inventor based in Pelham, NY (US). He has made significant contributions to the field of peptide technology, holding a total of four patents. His work focuses on innovative solutions that have the potential to impact medical science.

Latest Patents

Among his latest patents are the ATF5 peptide variants and their uses. These patents describe ATF5 peptides that feature a truncated ATF5 leucine zipper region and, optionally, a cell-penetrating region. The compositions comprising these ATF5 peptides are designed for methods that inhibit proliferation and promote cytotoxicity in neoplastic cells. This innovative approach could lead to advancements in cancer treatment.

Career Highlights

Barry Kappel is currently associated with Sapience Therapeutics, Inc., where he continues to develop his groundbreaking work in peptide technology. His career is marked by a commitment to advancing scientific knowledge and improving therapeutic options.

Collaborations

He has collaborated with notable colleagues, including Jimmy Andrew Rotolo and Gene Merutka, contributing to a dynamic research environment that fosters innovation.

Conclusion

Barry Jay Kappel's contributions to peptide technology exemplify the spirit of innovation in the medical field. His patents and ongoing work at Sapience Therapeutics, Inc. highlight the potential for significant advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…